Logo.jpg
Naloxone Market To Reach USD 2,478.6 Million By 2032 | DataHorizzon Research
April 16, 2024 08:00 ET | DataHorizzon Research
Fort Collins, Colorado, April 16, 2024 (GLOBE NEWSWIRE) -- The growing cases of opioid addiction are expected to drive the naloxone market. The alarming rise in opioid addiction and related...
22157.jpg
Global Naloxone Market to Reach $2.1 Billion by 2030 with a CAGR of 10.8% - Market Growth Driven by Increasing Drug Dependency and Public Awareness
April 03, 2024 11:20 ET | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Naloxone Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The future of...
Global Alexipharmic Drugs Market
Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region
March 12, 2024 13:46 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region" report has been added to ...
Global Antidote Market
Global Antidote Market Size, Share & Trends Analysis Report 2024-2030 - Snakebites and Surge in Number of Drug Overdoses Drives Demand for Antidotes
January 26, 2024 11:35 ET | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Antidote Market Size, Share & Trends Analysis Report by Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), Route Of...
cmi_logo.png
[Latest] Global Naloxone Market Size/Share Worth USD 2,470.2 Million by 2032 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
December 04, 2023 14:30 ET | Custom Market Insights
Austin, TX, USA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Naloxone Market Size, Trends and Insights By Type (Injectable, Intranasal), By...
(ACMT) Toxicology Investigators Consortium (ToxIC)
Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project
October 02, 2023 11:31 ET | American College of Medical Toxicology
Phoenix, AZ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- In September 2023, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) through its Broad...
ARC logo.png
Naloxone Market Projected to Attain a Value of USD 3,036.8 Million by 2032, Exhibiting a CAGR of 10.5% between 2023 and 2032
September 27, 2023 10:17 ET | Acumen Research and Consulting
LOS ANGELES, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The Naloxone Market is spearheading efforts to combat the opioid epidemic by providing advanced solutions for reversing opioid overdoses. The...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
June 22, 2023 07:30 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
May 25, 2023 16:26 ET | Adamis Pharmaceuticals Corporation
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of development candidates, including two clinical...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023 16:47 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in...